What are the diagnostic criteria for inpatient admission and the discharge criteria for outpatient management of diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Criteria for Admission and Discharge in DKA

For adults, admit to inpatient care if pH <7.30, bicarbonate <15 mEq/L, or blood glucose >250 mg/dL with moderate ketonuria/ketonemia; discharge when glucose <200 mg/dL, bicarbonate ≥18 mEq/L, and venous pH ≥7.30. 1

Inpatient Admission Criteria

Adults

The diagnostic and admission thresholds are clearly defined 1:

  • Blood glucose ≥250 mg/dL
  • Arterial pH <7.30
  • Bicarbonate <15 mEq/L
  • Moderate ketonuria or ketonemia

Severe DKA requiring ICU admission includes patients needing continuous insulin infusion, particularly those with profound acidosis or altered mental status 2, 1.

Pediatric Patients (<20 years)

Similar criteria apply 1:

  • Blood glucose ≥250 mg/dL
  • Venous pH <7.30
  • Bicarbonate <15 mEq/L
  • Moderate ketonuria or ketonemia

Mild DKA Considerations

Outpatient management may be appropriate for select patients with mild DKA 3:

  • pH ≥7.20 OR bicarbonate ≥10 mEq/L at presentation
  • In pediatric studies, 94% of patients meeting these criteria had resolution within 3 hours of outpatient therapy
  • This applies only to reliable patients with adequate follow-up and no comorbid conditions

Discharge Criteria

Resolution of DKA

All three criteria must be met before discharge 1:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH ≥7.30

Transition to Subcutaneous Insulin

Once DKA resolves 1:

  • If patient can eat, transition to subcutaneous insulin regimen
  • Continue IV insulin for 1-2 hours after first subcutaneous dose to prevent rebound ketoacidosis
  • If patient remains NPO, continue IV insulin and fluids

Important Discharge Considerations

Hyperglycemia at discharge is not a contraindication - Research shows that higher blood glucose at discharge (and in the 24 hours prior) is actually associated with lower readmission rates 4. This counterintuitive finding suggests that overly aggressive glucose control before discharge may not be beneficial.

Early discharge after acidosis resolution is safe - Discharging within 24 hours of acidosis resolution is not associated with higher readmission rates compared to longer observation periods 4.

Common Pitfalls to Avoid

Monitoring Ketones

  • Do not use nitroprusside method (urine ketones) to assess treatment response 1
  • β-hydroxybutyrate (β-OHB) is the preferred blood ketone measurement
  • During treatment, β-OHB converts to acetoacetic acid, which can falsely suggest worsening ketosis on urine tests

Premature Discontinuation of IV Insulin

  • Never stop IV insulin when glucose reaches 250-300 mg/dL 1
  • Ketonemia takes longer to clear than hyperglycemia
  • Add dextrose-containing fluids when glucose <250 mg/dL while continuing insulin infusion

Overdiagnosis

Nearly 28% of hospital admissions coded as DKA are misdiagnosed 5. Ensure strict adherence to diagnostic criteria to avoid unnecessary ICU admissions and IV insulin protocols.

Patient Education Before Discharge

Critical gaps exist in patient knowledge 6:

  • Only 21% of type 1 diabetes patients possess ketone testing supplies
  • Only 6% actually perform ketone testing
  • 71% of type 1 diabetes patients experience recurrent DKA episodes
  • Provide ketone testing supplies and education on sick-day rules before discharge

Special Populations

SGLT2 Inhibitor Users

Patients on SGLT2 inhibitors can develop euglycemic DKA (glucose may be <250 mg/dL) 6. These patients still require admission and IV insulin if they meet pH and bicarbonate criteria, even with "normal" glucose levels.

References

Guideline

hyperglycemic crises in diabetes.

Diabetes Care, 2004

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Research

Outpatient management of diabetic ketoacidosis.

American journal of diseases of children (1960), 1988

Research

How well do we need to control blood glucose before discharging DKA patients? A retrospective cohort study.

Journal of community hospital internal medicine perspectives, 2014

Research

Diabetic ketoacidosis diagnosis in a hospital setting.

Journal of osteopathic medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.